6,868 Shares in Integer Holdings Corporation $ITGR Bought by Corient Private Wealth LLC

Corient Private Wealth LLC bought a new position in shares of Integer Holdings Corporation (NYSE:ITGR) in the fourth quarter, HoldingsChannel.com reports. The firm bought 6,868 shares of the medical equipment provider’s stock, valued at approximately $539,000.

A number of other hedge funds also recently bought and sold shares of ITGR. Salomon & Ludwin LLC increased its stake in shares of Integer by 46.8% in the fourth quarter. Salomon & Ludwin LLC now owns 370 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 118 shares during the period. TD Private Client Wealth LLC grew its holdings in Integer by 1,037.5% in the 4th quarter. TD Private Client Wealth LLC now owns 455 shares of the medical equipment provider’s stock valued at $36,000 after buying an additional 415 shares during the last quarter. Parkside Financial Bank & Trust grew its holdings in Integer by 135.5% in the 4th quarter. Parkside Financial Bank & Trust now owns 464 shares of the medical equipment provider’s stock valued at $36,000 after buying an additional 267 shares during the last quarter. Arax Advisory Partners increased its position in Integer by 2,489.5% in the 4th quarter. Arax Advisory Partners now owns 492 shares of the medical equipment provider’s stock worth $39,000 after buying an additional 473 shares during the period. Finally, Farther Finance Advisors LLC increased its position in Integer by 193.2% in the 4th quarter. Farther Finance Advisors LLC now owns 519 shares of the medical equipment provider’s stock worth $41,000 after buying an additional 342 shares during the period. 99.29% of the stock is currently owned by institutional investors.

Integer Price Performance

NYSE:ITGR opened at $95.18 on Friday. The company has a 50-day moving average of $89.92 and a 200-day moving average of $86.31. The company has a market capitalization of $3.23 billion, a price-to-earnings ratio of 23.74, a PEG ratio of 2.27 and a beta of 0.64. Integer Holdings Corporation has a 52 week low of $62.00 and a 52 week high of $122.99. The company has a debt-to-equity ratio of 0.77, a quick ratio of 2.38 and a current ratio of 3.75.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, April 30th. The medical equipment provider reported $1.20 earnings per share for the quarter, missing analysts’ consensus estimates of $1.21 by ($0.01). Integer had a net margin of 7.64% and a return on equity of 12.83%. The business had revenue of $439.58 million during the quarter, compared to the consensus estimate of $426.48 million. During the same period in the previous year, the firm earned $1.31 EPS. The business’s revenue was up .5% compared to the same quarter last year. Integer has set its FY 2026 guidance at 5.830-6.400 EPS. As a group, equities research analysts anticipate that Integer Holdings Corporation will post 6.04 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Piper Sandler reissued an “overweight” rating and issued a $97.00 price objective (up from $87.00) on shares of Integer in a research report on Friday, May 1st. Citigroup boosted their target price on shares of Integer from $89.00 to $92.00 and gave the stock a “neutral” rating in a research report on Thursday, May 28th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Integer in a research report on Thursday, June 18th. Finally, Zacks Research cut Integer from a “hold” rating to a “strong sell” rating in a report on Monday, May 11th. Four equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $98.71.

Integer Company Profile

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.